Erel Joffe
Hematology & Oncology · New York, NYNPI 1831619063
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,800 of the $2,800 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, AstraZeneca.
Across 1 payment — averaging $2800.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
Across 46 payments — averaging $31,607 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Morphosys AG$735K
- Beigene, Ltd.$339K
- Amgen$228K
- Janssen Research & Development, LLC$128K
- Beigene AUS Pty Ltd$23K
What the payments were for
- Consulting fees$2,800100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $2,800 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CALQUENCE$2,800
How this compares
$2,800 in reported general payments places this provider in the 55th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in New York
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Ross LevineNew York$968K
- Joshua SabariNew York$761K
- Gail RobozNew York$738K
- Jeffrey LaurenceNew York$640K
- John AllanNew York$580K
- Ilan ShapiraNew York$475K
- John MascarenhasNew York$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.